Jump to main content
博士論文

Gemcitabine enhances rituximab-mediated complement-dependent cytotoxicity to B cell lymphoma by CD20 upregulation

Icons representing 博士論文
The cover of this title could differ from library to library. Link to Help Page

Gemcitabine enhances rituximab-mediated complement-dependent cytotoxicity to B cell lymphoma by CD20 upregulation

Persistent ID (NDL)
info:ndljp/pid/11634463
Material type
博士論文
Author
林, 和美ほか
Publisher
-
Publication date
2018-01-19
Material Format
Digital
Capacity, size, etc.
-
Name of awarding university/degree
東京慈恵会医科大学,博士 (医学)
View All

Notes on use at the National Diet Library

本資料は、掲載誌(URI)等のリンク先にある学位授与機関のWebサイトやCiNii DissertationsLeave the NDL website. から、本文を自由に閲覧できる場合があります。

Notes on use

Note (General):

type:thesissource:The Jikei University School of MedicinePubMed番号 : 26920337

Bibliographic Record

You can check the details of this material, its authority (keywords that refer to materials on the same subject, author's name, etc.), etc.

Digital

Material Type
博士論文
Author/Editor
林, 和美
ハヤシ, カズミ
Hayashi, Kazumi
Publication Date
2018-01-19
Publication Date (W3CDTF)
2018-01-19
Alternative Title
Gemcitabine enhances rituximab-mediated complement-dependent cytotoxicity to B cell lymphoma by CD20 upregulation
ゲムシタビンはB細胞性リンパ腫のCD20の発現を上昇させリツキシマブの補体依存性細胞障害を増強させる
Periodical title
Cancer science
Degree grantor/type
東京慈恵会医科大学
Date Granted
2016-12-14